 Connection
Connie Hess to Stroke
This is a "connection" page, showing publications Connie Hess has written about Stroke.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.442 |
|
|
|
-
Hess CN, Bonaca MP. Risk of remnants and remnant risk in peripheral artery disease. Eur Heart J. 2022 09 07; 43(34):3270-3272.
Score: 0.391
-
Hess CN, Clare RM, Neely ML, Tricoci P, Mahaffey KW, James SK, Alexander JH, Held C, Lopes RD, Fox KAA, White HD, Wallentin L, Armstrong PW, Harrington RA, Ohman EM, Roe MT. Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome. Am Heart J. 2017 May; 187:194-203.
Score: 0.266
-
Hess CN, Al-Khatib SM, Granger CB, Lopes R. A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE. Expert Rev Cardiovasc Ther. 2013 Sep; 11(9):1105-14.
Score: 0.209
-
Hess CN, Broderick S, Piccini JP, Alexander KP, Newby LK, Shaw LK, Mahaffey KW, Alexander JH, Peterson ED, Granger CB, Lopes RD. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. Am Heart J. 2012 Oct; 164(4):607-15.
Score: 0.196
-
Krantz MJ, Debus SE, Hsia J, Patel MR, Anand SS, Nehler MR, Hess CN, Capell WH, Bracken T, Szarek M, Mátyás L, Krievins DK, Nault P, Stefanov S, Haskell LP, Berkowitz SD, Muehlhofer E, Hiatt WR, Bauersachs RM, Bonaca MP. Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial. Eur Heart J. 2021 10 14; 42(39):4040-4048.
Score: 0.092
-
Desai U, Kharat A, Hess CN, Milentijevic D, Laliberté F, Zuckerman P, Benson J, Lefebvre P, Hiatt WR, Bonaca MP. Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization. J Med Econ. 2021 Jan-Dec; 24(1):402-409.
Score: 0.087
-
Pagidipati NJ, Clare RM, Keenan RT, Chiswell K, Roe MT, Hess CN. Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease. J Am Heart Assoc. 2018 08 21; 7(16):e009328.
Score: 0.074
-
Hess CN, Peterson ED, Peng SA, de Lemos JA, Fosbol EL, Thomas L, Bhatt DL, Saucedo JF, Wang TY. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation. J Am Coll Cardiol. 2015 Aug 11; 66(6):616-27.
Score: 0.060
-
Alkhalfan F, Wood M, Leon K, Gibson CM, Chi G, Grodzinsky A, Gornik HL, Wells BJ, Lewey J, Taylor A, Kadian-Dodov D, Hess CN, Henkin S, Lindley KJ, Wells G, Orford JL, Tam L, Kumbhani DJ, Norris S, Reyes C, Vitarello C, Naderi S, Kim ES. Factors associated with a complicated hospital course in patients with spontaneous coronary artery dissection: a report of the iSCAD registry. BMC Cardiovasc Disord. 2026 Apr 18; 26(1).
Score: 0.031
-
Ibrahim H, Kaltenbach LA, Hess CN, Recchia T, Effron MB, Stone GW, Wang TY. Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study. Catheter Cardiovasc Interv. 2019 03 01; 93(4):E204-E210.
Score: 0.019
-
Vora AN, Wang TY, Li S, Chiswell K, Hess C, Lopes RD, Rao SV, Peterson ED. Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines. J Am Heart Assoc. 2017 Aug 21; 6(8).
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|